Artikel mit Open-Access-Mandaten - Olivier DelattreWeitere Informationen
Nicht verfügbar: 22
Prüfen
Ewing sarcoma
TGP Grünewald, F Cidre-Aranaz, D Surdez, EM Tomazou, E de Álava, ...
Nature reviews Disease primers 4 (1), 5, 2018
Mandate: Fonds zur Förderung der wissenschaftlichen Forschung, Deutsche …
Prüfen
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
S De Brouwer, K De Preter, C Kumps, P Zabrocki, M Porcu, ...
Clinical cancer research 16 (17), 4353-4362, 2010
Mandate: Research Foundation (Flanders)
Prüfen
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
F Le Loarer, S Watson, G Pierron, VT de Montpreville, S Ballet, N Firmin, ...
Nature genetics 47 (10), 1200-1205, 2015
Mandate: National Institute of Health and Medical Research, France
Prüfen
SWI/SNF chromatin remodeling and human malignancies
J Masliah-Planchon, I Bièche, JM Guinebretière, F Bourdeaut, O Delattre
Annual Review of Pathology: Mechanisms of Disease 10 (1), 145-171, 2015
Mandate: National Institute of Health and Medical Research, France, Swiss Cancer League
Prüfen
Beta‐catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
S Fattet, C Haberler, P Legoix, P Varlet, A Lellouch‐Tubiana, S Lair, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009
Mandate: Fonds zur Förderung der wissenschaftlichen Forschung, National Institute of …
Prüfen
Revised risk estimation and treatment stratification of low-and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers
A Oberthuer, D Juraeva, B Hero, R Volland, C Sterz, R Schmidt, A Faldum, ...
Clinical Cancer Research 21 (8), 1904-1915, 2015
Mandate: Government of Spain
Prüfen
Extra‐renal non‐cerebral rhabdoid tumours
F Bourdeaut, P Fréneaux, B Thuille, C Bergeron, V Laurence, L Brugières, ...
Pediatric Blood & Cancer 51 (3), 363-368, 2008
Mandate: National Institute of Health and Medical Research, France
Prüfen
Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma
N Gruel, C Lucchesi, V Raynal, MJ Rodrigues, G Pierron, R Goudefroye, ...
European Journal of Cancer 46 (13), 2399-2407, 2010
Mandate: National Institute of Health and Medical Research, France
Prüfen
PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors
F Bielle, P Fréneaux, C Jeanne-Pasquier, A Maran-Gonzalez, ...
The American journal of surgical pathology 36 (8), 1141-1149, 2012
Mandate: US National Institutes of Health, Howard Hughes Medical Institute
Prüfen
The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors
J Caramel, S Medjkane, F Quignon, O Delattre
Oncogene 27 (14), 2035-2044, 2008
Mandate: National Institute of Health and Medical Research, France
Prüfen
STAG mutations in cancer
L Romero-Pérez, D Surdez, E Brunet, O Delattre, TGP Grünewald
Trends in cancer 5 (8), 506-520, 2019
Mandate: Deutsche Forschungsgemeinschaft
Prüfen
The ALK receptor in sympathetic neuron development and neuroblastoma
I Janoueix-Lerosey, L Lopez-Delisle, O Delattre, H Rohrer
Cell and tissue research 372, 325-337, 2018
Mandate: National Institute of Health and Medical Research, France
Prüfen
SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
D Rizzo, P Fréneaux, H Brisse, C Louvrier, D Lequin, A Nicolas, ...
The American Journal of Surgical Pathology 36 (7), 964-972, 2012
Mandate: National Institute of Health and Medical Research, France
Prüfen
Chromosome 1p loss evaluation in anaplastic oligodendrogliomas
A Idbaih, M Kouwenhoven, J Jeuken, C Carpentier, T Gorlia, JM Kros, ...
Neuropathology 28 (4), 440-443, 2008
Mandate: National Institute of Health and Medical Research, France
Prüfen
Conventional Chondrosarcoma in a Survivor of Rhabdoid Tumor: Enlarging The Spectrum of Tumors Associated With: SMARCB1: Germline Mutations
F Forest, A David, S Arrufat, G Pierron, D Ranchere-Vince, JL Stephan, ...
The American Journal of Surgical Pathology 36 (12), 1892-1896, 2012
Mandate: National Institute of Health and Medical Research, France
Prüfen
Small round cell sarcomas
F Cidre-Aranaz, S Watson, JF Amatruda, T Nakamura, O Delattre, ...
Nature Reviews Disease Primers 8 (1), 66, 2022
Mandate: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung
Prüfen
SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type
M Andrianteranagna, J Cyrta, J Masliah‐Planchon, K Nemes, A Corsia, ...
The Journal of Pathology 255 (1), 1-15, 2021
Mandate: Deutsche Forschungsgemeinschaft, National Institute of Health and Medical …
Prüfen
High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability
T He, D Surdez, JK Rantala, S Haapa-Paananen, J Ban, M Kauer, ...
Gene 596, 137-146, 2017
Mandate: Fonds zur Förderung der wissenschaftlichen Forschung, Government of Spain
Prüfen
Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe
T Bölling, G Braun-Munzinger, S Burdach, G Calaminus, A Craft, ...
Klinische Pädiatrie 227 (03), 108-115, 2015
Mandate: Cancer Research UK, National Institute for Health Research, UK
Prüfen
Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas
S El Zein, L Djeroudi, S Reynaud, D Guillemot, J Masliah‐Planchon, ...
Genes, Chromosomes and Cancer 61 (4), 200-205, 2022
Mandate: National Institute of Health and Medical Research, France
Angaben zur Publikation und Finanzierung werden automatisch von einem Computerprogramm ermittelt